Literature DB >> 11508427

The clinical meaning of functional outcome scores in children with juvenile arthritis.

H Dempster1, M Porepa, N Young, B M Feldman.   

Abstract

OBJECTIVE: The Childhood Health Assessment Questionnaire (CHAQ) is the most widely used measure of function in childhood arthritis and yields a score of 0 (no disability) to 3 (very severe disability). This study ascertained the cutoff levels for CHAQ scores that represent no, mild, moderate, and severe disability, to determine the minimal clinically important change in scores and to determine whether the minimal important change in scores is similar for parent-reported assessments and the self-assessments provided by their older children.
METHODS: One hundred thirty-six parents of children with arthritis were interviewed. They were asked to complete the CHAQ by assessing their child's functional status under 3 categories: current health, a hypothetical small improvement, and a hypothetical small worsening. They also completed a categorical scale of subjective disability. Those children who were > or = 10 years old also completed the CHAQ interview separately.
RESULTS: The pediatric patients had mostly no, mild, or moderate disability. For those children rated as having no disability, the median CHAQ score was 0. The median CHAQ scores corresponding to mild, mild-to-moderate, and moderate disability were 0.13, 0.63, and 1.75, respectively. The minimal clinically important improvement was a reduction in score of 0.13. The minimal clinically important deterioration was a median change in score of 0.75. This discrepancy may be due to the ceiling effect seen with the CHAQ. There were no significant differences when the children assessed themselves.
CONCLUSION: Clinicians, as well as researchers setting protocols, should aim for a mimimum improvement of 0.13 in the CHAQ score when treating pediatric patients with arthritis.

Entities:  

Mesh:

Year:  2001        PMID: 11508427     DOI: 10.1002/1529-0131(200108)44:8<1768::AID-ART312>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  37 in total

Review 1.  Outcome measures and medical progress: why outcome measures are needed in childhood arthritis.

Authors:  Francesco Zulian
Journal:  Curr Rheumatol Rep       Date:  2003-12       Impact factor: 4.592

2.  Examining the psychometric characteristics of the Dutch childhood health assessment questionnaire: room for improvement?

Authors:  T Takken; F van den Eijkhof; H Hoijtink; P J M Helders; J van der Net
Journal:  Rheumatol Int       Date:  2006-02-09       Impact factor: 2.631

Review 3.  Quality of life in children with systemic lupus erythematosus.

Authors:  L Nandini Moorthy; Margaret Peterson; Karen B Onel; Melanie J Harrison; Thomas J A Lehman
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

Review 4.  [Back to school physical education despite rheumatism : Development and testing of a sport scientific-based physical education certification].

Authors:  M Hartmann; J Merker; S Schrödl; M König; M Georgi; C Hinze; A Schwirtz; J-P Haas
Journal:  Z Rheumatol       Date:  2018-10       Impact factor: 1.372

5.  Factors influencing the quality of life of Moroccan patients with juvenile idiopathic arthritis.

Authors:  M Ezzahri; B Amine; S Rostom; D Badri; N Mawani; S Gueddari; S Shyen; M Wabi; F Moussa; R Abouqal; B Chkirate; N Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2014-01-21       Impact factor: 2.980

Review 6.  [New therapy approaches, better outcomes? : Results from inception cohorts for patients with juvenile idiopathic arthritis].

Authors:  C Sengler
Journal:  Z Rheumatol       Date:  2019-09       Impact factor: 1.372

7.  Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Turkish population and in Turkish patients with juvenile rheumatoid arthritis.

Authors:  A Ruhi Ozyürek; Dolunay Gürses; Zülal Ulger; Ertürk Levent; A Rahmi Bakiler; Afig Berdeli
Journal:  Clin Rheumatol       Date:  2006-07-12       Impact factor: 2.980

8.  Patient-reported Outcomes across Categories of Juvenile Idiopathic Arthritis.

Authors:  Alysha J Taxter; E Paul Wileyto; Edward M Behrens; Pamela F Weiss
Journal:  J Rheumatol       Date:  2015-09-01       Impact factor: 4.666

9.  [Remission in pediatric rheumatology].

Authors:  H-L Huppertz
Journal:  Z Rheumatol       Date:  2013-05       Impact factor: 1.372

10.  Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study.

Authors:  Kimme L Hyrich; Sham D Lal; Helen E Foster; Judith Thornton; Navid Adib; Eileen Baildam; Janet Gardner-Medwin; Lucy R Wedderburn; Alice Chieng; Joyce Davidson; Wendy Thomson
Journal:  Rheumatology (Oxford)       Date:  2009-11-19       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.